Related references
Note: Only part of the references are listed.Tissue-specific responses to loss of transglutaminase 2
Stephanie Deasey et al.
AMINO ACIDS (2013)
The role of TG2 in ECV304-related vasculogenic mimicry
Richard A. Jones et al.
AMINO ACIDS (2013)
Imidazolium-based warheads strongly influence activity of water-soluble peptidic transglutaminase inhibitors
Eduard Badarau et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
TG2, a novel extracellular protein with multiple functions
Zhuo Wang et al.
AMINO ACIDS (2012)
Characterization of Heparin-binding Site of Tissue Transglutaminase ITS IMPORTANCE IN CELL SURFACE TARGETING, MATRIX DEPOSITION, AND CELL SIGNALING
Zhuo Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
RhoB is associated with the anti-angiogenic effects of celiac patient transglutaminase 2-targeted autoantibodies
Stefania Martucciello et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2012)
The role of tissue transglutaminase (TG2) in regulating the tumour progression of the mouse colon carcinoma CT26
Panayiotis Kotsakis et al.
AMINO ACIDS (2011)
A cell penetrating peptide derived from azurin inhibits angiogenesis and tumor growth by inhibiting phosphorylation of VEGFR-2, FAK and Akt
Rajeshwari R. Mehta et al.
ANGIOGENESIS (2011)
Beyond VEGF: Inhibition of the Fibroblast Growth Factor Pathway and Antiangiogenesis
Christopher Lieu et al.
CLINICAL CANCER RESEARCH (2011)
A Comprehensive Characterization Study of Human Bone Marrow MSCs with an Emphasis on Molecular and Ultrastructural Properties
Erdal Karaoz et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2011)
Cytosolic Guanine Nucledotide Binding Deficient Form of Transglutaminase 2 (R580a) Potentiates Cell Death in Oxygen Glucose Deprivation
Gozde Colak et al.
PLOS ONE (2011)
Transglutaminase-2: a new endostatin partner in the extracellular matrix of endothelial cells
Clement Faye et al.
BIOCHEMICAL JOURNAL (2010)
Inhibition of transglutaminase 2 mitigates transcriptional dysregulation in models of Huntington's disease
Stephen J. McConoughey et al.
EMBO MOLECULAR MEDICINE (2010)
RGD-independent Cell Adhesion via a Tissue Transglutaminase-Fibronectin Matrix Promotes Fibronectin Fibril Deposition and Requires Syndecan-4/2 and α5β1 Integrin Co-signaling
Zhuo Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Anchorage of VEGF to the extracellular matrix conveys differential signaling responses to endothelial cells
Tom T. Chen et al.
JOURNAL OF CELL BIOLOGY (2010)
Regulation of fibronectin matrix assembly and capillary morphogenesis in endothelial cells by Rho family GTPases
Samantha Fernandez-Sauze et al.
EXPERIMENTAL CELL RESEARCH (2009)
Targeting angiogenesis in hepatocellular carcinoma: focus on VEGF and bevacizumab
Richard S. Finn et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2009)
Over-expression of integrin β3 can partially overcome the defect of integrin β3 signaling in transglutaminase 2 null macrophages
Beata Toth et al.
IMMUNOLOGY LETTERS (2009)
Transglutaminases and Disease: Lessons From Genetically Engineered Mouse Models and Inherited Disorders
Siiri E. Iismaa et al.
PHYSIOLOGICAL REVIEWS (2009)
Synthesis of potent water-soluble tissue transglutaminase inhibitors
Martin Griffin et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
The Molecular Basis of Class Side Effects Due to Treatment with Inhibitors of the VEGF/VEGFR Pathway
Jeanine M. Roodhart et al.
CURRENT CLINICAL PHARMACOLOGY (2008)
Vinculin controls focal adhesion formation by direct interactions with talin and actin
Jonathan D. Humphries et al.
JOURNAL OF CELL BIOLOGY (2007)
Matrix changes induced by transglutaminase 2 lead to inhibition of angiogenesis and tumor growth
R. A. Jones et al.
CELL DEATH AND DIFFERENTIATION (2006)
Biology of vascular endothelial growth factors
Himadri Roy et al.
FEBS LETTERS (2006)
Transglutaminases: Nature's biological glues
M Griffin et al.
BIOCHEMICAL JOURNAL (2002)
Tissue transglutaminase is an integrin-binding adhesion coreceptor for fibronectin
SS Akimov et al.
JOURNAL OF CELL BIOLOGY (2000)
Share Paper
